Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore
- PMID: 19060123
- PMCID: PMC2643894
- DOI: 10.1152/ajpheart.01012.2008
Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore
Abstract
Aldose reductase (AR), a member of the aldo-keto reductase family, has been demonstrated to play a central role in mediating myocardial ischemia-reperfusion (I/R) injury. Recently, using transgenic mice broadly overexpressing human AR (ARTg), we demonstrated that AR is an important component of myocardial I/R injury and that inhibition of this enzyme protects heart from I/R injury (20-22, 48, 49, 56). To rigorously delineate mechanisms by which AR pathway influences myocardial ischemic injury, we investigated the role played by reactive oxygen species (ROS), antioxidant enzymes, and mitochondrial permeability transition (MPT) pore opening in hearts from ARTg or littermates [wild type (WT)] subjected to I/R. MPT pore opening after I/R was determined using mitochondrial uptake of 2-deoxyglucose ratio, while H2O2 was measured as a key indicator of ROS. Myocardial 2-deoxyglucose uptake ratio and calcium-induced swelling were significantly greater in mitochondria from ARTg mice than in WT mice. Blockade of MPT pore with cyclosphorin A during I/R reduced ischemic injury significantly in ARTg mice hearts. H2O2 measurements indicated mitochondrial ROS generation after I/R was significantly greater in ARTg mitochondria than in WT mice hearts. Furthermore, the levels of antioxidant GSH were significantly reduced in ARTg mitochondria than in WT. Resveratrol treatment or pharmacological blockade of AR significantly reduced ROS generation and MPT pore opening in mitochondria of ARTg mice hearts exposed to I/R stress. This study demonstrates that MPT pore opening is a key event by which AR pathway mediates myocardial I/R injury, and that the MPT pore opening after I/R is triggered, in part, by increases in ROS generation in ARTg mice hearts. Therefore, inhibition of AR pathway protects mitochondria and hence may be a useful adjunct for salvaging ischemic myocardium.
Figures






Similar articles
-
Central role for aldose reductase pathway in myocardial ischemic injury.FASEB J. 2004 Aug;18(11):1192-9. doi: 10.1096/fj.03-1400com. FASEB J. 2004. PMID: 15284219
-
Aldose reductase modulates cardiac glycogen synthase kinase-3β phosphorylation during ischemia-reperfusion.Am J Physiol Heart Circ Physiol. 2012 Aug 1;303(3):H297-308. doi: 10.1152/ajpheart.00999.2011. Epub 2012 Jun 1. Am J Physiol Heart Circ Physiol. 2012. PMID: 22661511 Free PMC article.
-
Extent of mitochondrial hexokinase II dissociation during ischemia correlates with mitochondrial cytochrome c release, reactive oxygen species production, and infarct size on reperfusion.J Am Heart Assoc. 2012 Dec 31;2(1):e005645. doi: 10.1161/JAHA.112.005645. J Am Heart Assoc. 2012. PMID: 23525412 Free PMC article.
-
The role of mitochondria in protection of the heart by preconditioning.Biochim Biophys Acta. 2007 Aug;1767(8):1007-31. doi: 10.1016/j.bbabio.2007.05.008. Epub 2007 Jun 2. Biochim Biophys Acta. 2007. PMID: 17631856 Free PMC article. Review.
-
Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury.Mol Cell Biochem. 1997 Sep;174(1-2):167-72. Mol Cell Biochem. 1997. PMID: 9309682 Review.
Cited by
-
Postischemic deactivation of cardiac aldose reductase: role of glutathione S-transferase P and glutaredoxin in regeneration of reduced thiols from sulfenic acids.J Biol Chem. 2010 Aug 20;285(34):26135-48. doi: 10.1074/jbc.M110.146423. Epub 2010 Jun 10. J Biol Chem. 2010. PMID: 20538586 Free PMC article.
-
Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model.Circ Res. 2010 May 14;106(9):1449-58. doi: 10.1161/CIRCRESAHA.109.213447. Circ Res. 2010. PMID: 20466987 Free PMC article. Review.
-
Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications.Front Endocrinol (Lausanne). 2021 Mar 11;12:636267. doi: 10.3389/fendo.2021.636267. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33776930 Free PMC article. Review.
-
The Role of Oxidative Stress in Myocardial Ischemia and Reperfusion Injury and Remodeling: Revisited.Oxid Med Cell Longev. 2016;2016:1656450. doi: 10.1155/2016/1656450. Epub 2016 May 25. Oxid Med Cell Longev. 2016. PMID: 27313825 Free PMC article. Review.
-
Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes.Circ Res. 2013 Aug 16;113(5):603-16. doi: 10.1161/CIRCRESAHA.113.302095. Circ Res. 2013. PMID: 23948585 Free PMC article. Review.
References
-
- Bernardi P, PetronelliV, Di Lisa F, Forte M. A mitochondrial perspective on cell death. Trends Biochem Sci 26: 112–117, 2001. - PubMed
-
- Chung SS, Ho EC, Lam KS, Chung SK. Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 8, Suppl 3: S233–S236, 2003. - PubMed
-
- Clarke SJ, Khaliulin I, Das M, Parker JE, Heesom KJ, Halestrap AP. Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation. Circ Res 102: 1082–1090, 2008. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials